Tapewire

Nasdaq · USD

LGND

LIGAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3825
SEC CIK
0000886163
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 131 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202508
Jan 202605
Feb 202605
Mar 2026032
Apr 2026011
May 2026014
Jun 2026016
Jul 202608
Aug 2026012
Sep 202606
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 12, 2026 Filed May 15, 2026 01:08 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 459 $0.00 Strike: $69.51 $0.00
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · derivative · entry 10

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,575

Underlying: Common Stock · 459 shares

Expires 2026-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2017, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
May 12, 2026 Filed May 15, 2026 01:08 UTC SaleCommon Stock 459 $224.00 $102,816.00
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 7

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,786

Read SEC document
May 12, 2026 Filed May 15, 2026 01:08 UTC Exercise / conversionCommon Stock 459 $69.51 $31,905.09
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 6

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $52.27 $0.00
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · derivative · entry 9

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,444

Underlying: Common Stock · 5,000 shares

Expires 2032-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F9 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 800 $234.02 $187,214.16
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 8

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,382

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F8 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $233.8200 to $234.1100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,420 $232.92 $330,749.24
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 7

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,182

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F7 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $232.5400 to $233.3300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 780 $232.04 $180,991.12
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 6

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,602

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $231.5200 to $232.4900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 370 $230.87 $85,421.60
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 5

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,382

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $230.4300 to $231.3500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 98 $229.71 $22,511.44
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 4

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,752

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $229.4000 to $230.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 932 $228.75 $213,198.45
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 3

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,850

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $228.4000 to $229.3000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 600 $227.45 $136,469.58
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 2

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,782

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $227.0400 to $227.9200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 5, 2026 00:20 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionCommon Stock 5,000 $52.27 $261,350.00
Disclosure

SEC source: 0002001011-26-000046 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document
May 01, 2026 Filed May 15, 2026 01:08 UTC SaleCommon Stock 116 $234.09 $27,153.89
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 5

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,786

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $233.6800 to $234.2400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 15, 2026 01:08 UTC SaleCommon Stock 105 $232.57 $24,419.89
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 4

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,902

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $232.2000 to $232.9300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 15, 2026 01:08 UTC SaleCommon Stock 165 $231.87 $38,258.07
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 3

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,007

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $231.1200 to $232.0700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 15, 2026 01:08 UTC SaleCommon Stock 1 $229.87 $229.87
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,172

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

Read SEC document
May 01, 2026 Filed May 15, 2026 01:08 UTC SaleCommon Stock 80 $227.37 $18,189.40
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,173

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $227.1550 to $227.5800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 23:43 UTC SaleCommon Stock 159 $204.26 $32,477.77
Disclosure

SEC source: 0002001011-26-000038 · primary_doc.xml · nonDerivative · entry 5

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,253

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.0050 to $204.5400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 23:43 UTC SaleCommon Stock 43 $202.91 $8,725.22
Disclosure

SEC source: 0002001011-26-000038 · primary_doc.xml · nonDerivative · entry 4

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,412

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.8550 to $203.6550. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 23:43 UTC SaleCommon Stock 79 $202.42 $15,991.36
Disclosure

SEC source: 0002001011-26-000038 · primary_doc.xml · nonDerivative · entry 3

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,455

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.0750 to $202.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 23:43 UTC SaleCommon Stock 40 $201.24 $8,049.40
Disclosure

SEC source: 0002001011-26-000038 · primary_doc.xml · nonDerivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,534

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.0050 to $201.4650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 23:43 UTC SaleCommon Stock 146 $199.97 $29,196.34
Disclosure

SEC source: 0002001011-26-000038 · primary_doc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,574

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.6900 to $200.3150. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $52.27 $0.00
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · derivative · entry 8

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,444

Underlying: Common Stock · 5,000 shares

Expires 2032-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F8 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 337 $204.50 $68,917.38
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · nonDerivative · entry 7

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,382

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F7 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.0100 to $204.8200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 963 $203.22 $195,702.59
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · nonDerivative · entry 6

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,719

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.9900 to $203.7100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 700 $201.90 $141,327.97
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · nonDerivative · entry 5

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,682

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.6500 to $202.1900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,238 $200.94 $248,767.31
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · nonDerivative · entry 4

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,382

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.6000 to $201.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,302 $199.72 $260,038.17
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · nonDerivative · entry 3

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,620

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.4600 to $200.3300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 460 $198.85 $91,470.68
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · nonDerivative · entry 2

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,922

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $198.4000 to $199.3500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:56 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionCommon Stock 5,000 $52.27 $261,350.00
Disclosure

SEC source: 0002001011-26-000037 · primary_doc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document
March 23, 2026 Filed Mar 25, 2026 15:13 UTC SaleCommon Stock 1,000 $207.87 $207,872.70
Disclosure

SEC source: 0001104659-26-034308 · tm269702-1_4seq1.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,793

F1 · security: These securities, as represented in Column 5, include a grant of 1,209 restricted shares approved by the Board of Directors of the Company at the 2025 Meeting held 6 June 2025, which shares were previously reported on a Form 4 for this Reporting Person dated 10 June 2025, and are included on this Form 4 only to report that they will vest in full within six (6) months from the date hereof.

F2 · price: The price, as represented in Column 4, represents an average price per share of the following transactions on 23 March 2026: 100 shares at $208.055000, 17 shares at $207.980000, and 883 shares at $207.850000.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 23:29 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,405 $0.00 Strike: $92.65 $0.00
Disclosure

SEC source: 0002001011-26-000026 · edgardoc.xml · derivative · entry 3

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,405 shares

Expires 2028-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.

F2 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 23:29 UTC
Espinoza OctavioChief Financial Officer
SaleCommon Stock 3,057 $225.00 $687,825.00
Disclosure

SEC source: 0002001011-26-000026 · edgardoc.xml · nonDerivative · entry 2

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,010

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 23:29 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 2,405 $92.65 $222,823.25
Disclosure

SEC source: 0002001011-26-000026 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.

Read SEC document
March 06, 2026 Filed Mar 31, 2026 21:53 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,161 $0.00 Strike: $114.15 $0.00
Disclosure

SEC source: 0002001011-26-000036 · primary_doc.xml · derivative · entry 3

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,161 shares

Expires 2028-06-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This Option was previously reported as a Grant of 2,474 shares, which vested in full on June 6, 2019, at an exercise price of $195.91 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
March 06, 2026 Filed Mar 31, 2026 21:53 UTC SaleCommon Stock 2,161 $200.76 $433,842.36
Disclosure

SEC source: 0002001011-26-000036 · primary_doc.xml · nonDerivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,724

Read SEC document
March 06, 2026 Filed Mar 31, 2026 21:53 UTC Exercise / conversionCommon Stock 2,161 $114.15 $246,678.15
Disclosure

SEC source: 0002001011-26-000036 · primary_doc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $52.27 $0.00
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · derivative · entry 13

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,444

Underlying: Common Stock · 5,000 shares

Expires 2032-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F11 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,142 $208.87 $238,532.28
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 12

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,869

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F10 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $208.6000 to $208.9700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,446 $208.12 $300,939.06
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 11

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,011

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F9 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $207.6700 to $208.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 612 $207.01 $126,689.45
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 10

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,457

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F8 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $206.6800 to $207.5100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 340 $206.37 $70,164.78
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 9

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,069

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F7 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $205.6000 to $206.5400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 460 $205.18 $94,381.88
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 8

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,409

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.8400 to $205.5700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 200 $204.17 $40,834.00
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 7

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,869

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $203.8600 to $204.4800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 300 $201.70 $60,510.00
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 6

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,069

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 93 $200.62 $18,657.89
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 5

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,369

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.5800 to $200.8700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 207 $199.96 $41,390.89
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 4

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,462

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.8800 to $200.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 100 $199.01 $19,900.50
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 3

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,669

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 100 $197.70 $19,769.54
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 2

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,769

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.5800 to $198.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 23:51 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionCommon Stock 5,000 $52.27 $261,350.00
Disclosure

SEC source: 0002001011-26-000024 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,869

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.